Skip to main content

Zylet Bausch & Lomb - Treatment for Inflammatory Ocular Conditions

Zylet is a corticosteroid and antibiotic combination for the treatment of steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of infection exists. Zylet will be available in the United States early in the first quarter of 2005.

Related articles

Zylet (loteprednol and tobramycin) FDA Approval History

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.